
What We’re Reading: Legal Challenges to Health Equity Programs; Children Underrepresented in COVID-19 Clinical Trials; China’s Surge in Respiratory Illness
Lawsuits target initiatives aimed at reducing racial disparities; less than 10% of trials for COVID-19 treatments included children in the first 3 years of the pandemic; the World Health Organization requests more information on increased respiratory illnesses in China.
Legal Challenges Threaten Programs Addressing Racial Disparities in Health Care
Legal actions challenging programs designed to address racial disparities in health care, such as the Abundant Birth Project in San Francisco, raise concerns about the potential impact on efforts to reduce racial inequities,
Children Underrepresented in US COVID-19 Clinical Trials Despite Significant Infection Rate
A research letter published in JAMA Health Forum reveals that less than 10% of interventional COVID-19 trials conducted in the United States during the first 3 years of the pandemic included children, despite this age group accounting for 18% of infections,
China Says Surge in Respiratory Illnesses Not Caused by Novel Virus
The recent surge in respiratory illnesses across China, which prompted the World Health Organization (WHO) to seek more information, is caused by known pathogens such as the flu and common viruses, according to China's health ministry,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.